Company / Free Cash Flow
Twist Bioscience Corp Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$75.6M
FY2025
5-year range
-$226.2M / -$69.2M
FY2021-FY2025
Trend
-9.3%
vs FY2024
Sector context
#93 of 192
Health Care
What the data says
At -$76M, Twist Bioscience Corp's free cash flow ranks #93 of 192 in the Health Care sector. Free Cash Flow has fluctuated over the past 9 years, ranging from -$226M in FY2022 to -$58M in FY2017.
Based on SEC 10-K filings.
-$76M in FY2025.
Improved from -$170M to -$76M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#93 of 192 in Health CareTop 48% of 192This company -$75.6M Sector average $474.2M
▼
-116.0% below sector average
Key checks
Key Insights
- In FY2025, free cash flow decreased 9.3% year-over-year.
- Ranks #93 out of 192 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2017.
- Lowest free cash flow in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$75.6M | -9.3% |
| FY2024 | -$69.2M | +59.4% |
| FY2023 | -$170.3M | +24.7% |
| FY2022 | -$226.2M | -62.4% |
| FY2021 | -$139.3M | +8.4% |
| FY2020 | -$152.1M | -48.1% |
| FY2019 | -$102.7M | -47.0% |
| FY2018 | -$69.9M | -20.7% |
| FY2017 | -$57.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026